2025 annual financial data
Castle Biosciences 2025 Operating margin
Castle Biosciences 2025 operating margin with verified reported values.
Direct answer
Operating margin was -12.44%.
Operating income was -42,810,000 USD and net income was -24,158,000 USD.
Operating cash flow was 64,347,000 USD.
Get free Castle Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 344,229,000 USD
- Operating income
- -42,810,000 USD
- Net income
- -24,158,000 USD
- Operating cash flow
- 64,347,000 USD